Targeting of low-dose CT screening according to the risk of lung-cancer death. - Wikidata - awgldk - TriplyDB

Targeting of low-dose CT screening according to the risk of lung-cancer death.

Targeting of low-dose CT screening according to the risk of lung-cancer death.

http://www.wikidata.org/entity/Q37198867

about

Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literature Lung cancer screening in patients with chronic obstructive pulmonary disease Biomarkers of risk to develop lung cancer in the new screening era Early detection of lung cancer Pulmonary nodules and CT screening: the past, present and future Implementing lung cancer screening in the real world: opportunity, challenges and solutions Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement Update in Lung Cancer 2014 Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?Lung Cancer Gene Signatures and Clinical Perspectives Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention Lung cancer screening with low-dose computed tomography for primary care providers US lung cancer trends by histologic type Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model Database Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence.Demographic, Healthcare, and Contextual Factors Associated with Smoking Status Among Sexual Minority Women A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells.Noninvasive Quantitative Imaging-based Biomarkers and Lung Cancer Screening.Improving selection criteria for lung cancer screening. The potential role of emphysema.ATS Core Curriculum 2014: part I. Adult pulmonary medicine.Time to smoke first morning cigarette and lung cancer in a case-control study.Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.Screening: A risk-based framework to decide who benefits from screening Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force Buccal microRNA dysregulation in lung field carcinogenesis: gender-specific implications Time-varying pattern of postoperative recurrence risk of early-stage (T1a-T2bN0M0) non-small cell lung cancer (NSCLC): results of a single-center study of 994 Chinese patients.Contourlet textual features: improving the diagnosis of solitary pulmonary nodules in two dimensional CT images Buccal spectral markers for lung cancer risk stratification.Serum uric acid and the risk of respiratory disease: a population-based cohort study.Next steps and barriers to implementing lung cancer screening with low-dose CT.How does semi-automated computer-derived CT measure of breast density compare with subjective assessments to assess mean glandular breast density, in patients with breast cancer?Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling.Cost-effectiveness of CT screening in the National Lung Screening Trial.

P2860

Q23911871-4FCCE693-ECEB-4FD4-8C92-4AD9425FDA1C Q26747777-DE392FE7-89CF-4F30-9B24-AEC12AA623ED Q26747784-7634E8CD-26AA-4DC5-AC64-E43CCA4A61B1 Q26751228-C032FE3C-AEFC-453E-AE66-15098965597D Q26766010-18954333-C82C-4F43-8571-8BF70057FA15 Q26784107-0CAEC243-80B9-4F7B-9D27-7F9D4BFFA5DA Q26799888-C4F21294-86CC-4E61-B306-86E2FF999C8A Q26829758-4354E69E-C86D-46BB-A83F-4AA1A2557A55 Q27021984-5DB40DD6-1540-402A-9947-BED003E6349A Q27027385-A5826938-240D-43FC-8829-B5522F42F14D Q28384727-657300E6-1853-46B1-B9FF-D314C4193132 Q28386729-E9024E6B-4757-422E-97C5-D5D94ABD3D1A Q28387769-38B8FFAC-450D-4AC4-AD25-137D741935AB Q28388931-37DDE483-F254-4FD3-8120-3061C89B17FC Q28390878-0EE60AB3-6711-4D7C-AE51-745B612689FD Q28395426-40B30270-F5B3-4D2C-AA3C-8992F3F7B7A3 Q28646602-0319E863-8917-4FC5-85E1-240955F97CA5 Q30587070-3CEB07F6-818A-4F38-A4B5-292E534F459A Q31112168-6B6A70F5-2EC7-479F-944A-843C74493233 Q31143342-0826C97D-42DD-4424-886A-3BC83CAE927C Q33573991-A224EDC9-847A-48EC-B96D-DD92D3900558 Q33623634-89C6A320-1FA7-4C63-9AC3-82D66047AD82 Q33735610-1157B997-3878-4D19-AB5A-5D758D0A60A5 Q33735712-BD66F41F-5BDA-4410-A266-DF71244492B8 Q33786162-4030CBDE-470E-47ED-B9AB-992D01F9D072 Q33813187-3F2EC4DE-BEFF-48EF-BB03-9A44EE2AFD6D Q33847952-3098B035-1342-4B74-975C-4F4301839C2E Q33894116-428B481F-1966-4ED4-B177-9E1FDD526094 Q33978331-350CAD14-D4EB-449C-925D-5F1EA2AF80B0 Q34086886-127C3412-39AA-4322-8940-508DE2AD5849 Q34155998-A62F757E-7FA4-4EB1-A128-41A9EC622573 Q34255107-37A86F03-231E-402B-8C73-F13B18B3ED4E Q34317852-D4285D15-783A-4FBE-A85F-9152E46D0178 Q34431206-9BD10F0E-FD5D-4B15-96CD-B31B961628AC Q34568173-51B1889C-4FB5-4237-BD1C-2DC9015E8832 Q34568198-581B709E-6894-4F99-81D0-81D333FBDACE Q34611247-76B2464C-2030-431C-9620-AC7583A672C7 Q34747013-30031497-DFE7-4E7E-AD1F-8E0753E5B417 Q34860197-DC992F3C-878B-4383-B177-B923E019F9DC Q35104187-6F68D5ED-7166-4493-95AA-AD28FF758E36

P2860

Targeting of low-dose CT screening according to the risk of lung-cancer death.

http://www.wikidata.org/entity/Q37198867

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting of low-dose CT screening according to the risk of lung-cancer death.

@en

Targeting of low-dose CT screening according to the risk of lung-cancer death.

@nl

type

label

Targeting of low-dose CT screening according to the risk of lung-cancer death.

@en

Targeting of low-dose CT screening according to the risk of lung-cancer death.

@nl

prefLabel

Targeting of low-dose CT screening according to the risk of lung-cancer death.

@en

Targeting of low-dose CT screening according to the risk of lung-cancer death.

@nl

P1433

Q37198867-E254E2EE-F958-44CB-8E49-795172F6FEF4

P1476

Q37198867-BF96433C-6CA2-438F-9CF1-0DBD45172886

P2093

Q37198867-1E331100-86E1-46D8-8EC0-077610306681

Q37198867-33340A66-5E09-457E-9D68-98DF5AFBDD3F

Q37198867-6F575B04-B348-433A-B0A3-5A5F9307218F

Q37198867-89157CAE-5B82-4941-8E01-EC43CC0941C1

Q37198867-8BFC9E3C-9BC0-4B28-B7AB-96A2C3B6F918

Q37198867-CEF81567-585E-493E-A809-8982865D401D

Q37198867-D2A76ED3-2508-40B6-943F-93D1355B168C

Q37198867-DDDBDC71-61A7-4697-BF39-B44FC53D104F

P2860

Q37198867-0AB72B14-F1A2-4DA0-8C9D-9BA6D72A5C90

Q37198867-0AFC2852-63F9-4B01-B665-73303F226797

Q37198867-0ECD6AAF-105D-44F1-A37E-0F8FCDAC73C2

Q37198867-0F15C93D-6799-407E-8C7F-ADFFFBE7C29F

Q37198867-47842DDB-25B2-4808-95A7-A63B84CFA7B0

Q37198867-4FDAE86A-620D-4F71-B9C6-7670984C3254

Q37198867-5DEC6873-E7BC-40F4-8628-45CAC138C871

Q37198867-5F33A3A0-3253-45C5-A8AD-55E0AC4651B7

Q37198867-80AFE5D6-E9E6-45BB-AC65-DBAB95A21E6D

Q37198867-8704657E-EBFE-4EB9-8355-C3BC2833AA4E

P304

Q37198867-F6A83B4F-B5B6-4413-90F3-0A93D0EDE298

P31

Q37198867-2A6AA46C-6627-4383-BFCF-5E0A1B9D4262

P356

Q37198867-2F16D791-DBAF-4E89-BBBD-A63BB499DAD1

P407

Q37198867-A03D0C1C-175E-4D7F-8F72-A7A7E8B5AF86

P433

Q37198867-B4C88ACB-7820-4366-9FA1-EA48D68941E5

P478

Q37198867-9DF04918-ADE9-493F-8484-B716C956597A

P50

Q37198867-6A192158-248D-432E-AEFA-DFEFFAB1B860

P577

Q37198867-5C82B376-0FE1-451A-B6C5-9D53C07D7100

P5875

Q37198867-02A5134F-370F-4B23-9479-3CFBF4ACDAF6

P698

Q37198867-8CD0C45C-E8A5-4566-A78E-71FE44B24FBA

P932

Q37198867-D39D751E-9112-499A-B61F-F506EA09288F

P356

P1433

The New England Journal of Medicine

P1476

Targeting of low-dose CT screening according to the risk of lung-cancer death.

@en

P2093

Anil K Chaturvedi

http://www.w3.org/2001/XMLSchema#string

Christine D Berg

http://www.w3.org/2001/XMLSchema#string

Gerard A Silvestri

http://www.w3.org/2001/XMLSchema#string

Hormuzd A Katki

http://www.w3.org/2001/XMLSchema#string

Mary Korch

http://www.w3.org/2001/XMLSchema#string

Neil E Caporaso

http://www.w3.org/2001/XMLSchema#string

Stephanie A Kovalchik

http://www.w3.org/2001/XMLSchema#string

Tom L Riley

http://www.w3.org/2001/XMLSchema#string

P2860

Benefits and harms of CT screening for lung cancer: a systematic review

Cancer statistics, 2013

How should meta-regression analyses be undertaken and interpreted?

Reduced lung-cancer mortality with low-dose computed tomographic screening

Cigarette smoking among adults and trends in smoking cessation - United States, 2008

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL

American Cancer Society lung cancer screening guidelines.

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue fra

The National Lung Screening Trial: overview and study design.

P304

245-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1301851

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P50

Martin C Tammemagi

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249996587

http://www.w3.org/2001/XMLSchema#string

P698

23863051

http://www.w3.org/2001/XMLSchema#string

P932

3783654

http://www.w3.org/2001/XMLSchema#string